Safety of Empagliflozin As Add-on Therapy in Patients With Uncontrolled Type 2 Diabetes Mellitus. Khwaja Yunus Ali Medical College Journal 2026, 16 (3), 119-122. https://doi.org/10.3329/kyamcj.v16i3.88022.